NO963066L - Substituerte 3-aryliden-7-azaoksindolforbindelser og fremgangsmåte for deres fremstilling - Google Patents

Substituerte 3-aryliden-7-azaoksindolforbindelser og fremgangsmåte for deres fremstilling

Info

Publication number
NO963066L
NO963066L NO963066A NO963066A NO963066L NO 963066 L NO963066 L NO 963066L NO 963066 A NO963066 A NO 963066A NO 963066 A NO963066 A NO 963066A NO 963066 L NO963066 L NO 963066L
Authority
NO
Norway
Prior art keywords
nch2oh
choh
alkyl
image
pct
Prior art date
Application number
NO963066A
Other languages
English (en)
Norwegian (no)
Other versions
NO963066D0 (no
Inventor
Franco Buzzetti
Maria Gabriella Brasca
Antonio Longo
Dario Ballinari
Original Assignee
Pharmacia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Spa filed Critical Pharmacia Spa
Publication of NO963066D0 publication Critical patent/NO963066D0/no
Publication of NO963066L publication Critical patent/NO963066L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
NO963066A 1994-11-28 1996-07-23 Substituerte 3-aryliden-7-azaoksindolforbindelser og fremgangsmåte for deres fremstilling NO963066L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9423997A GB9423997D0 (en) 1994-11-28 1994-11-28 Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
PCT/EP1995/004247 WO1996016964A1 (en) 1994-11-28 1995-10-30 Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation

Publications (2)

Publication Number Publication Date
NO963066D0 NO963066D0 (no) 1996-07-23
NO963066L true NO963066L (no) 1996-07-23

Family

ID=10765093

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963066A NO963066L (no) 1994-11-28 1996-07-23 Substituerte 3-aryliden-7-azaoksindolforbindelser og fremgangsmåte for deres fremstilling

Country Status (22)

Country Link
US (1) US5719135A (de)
EP (1) EP0741726B1 (de)
JP (1) JPH09508924A (de)
CN (1) CN1139929A (de)
AT (1) ATE186727T1 (de)
AU (1) AU3926295A (de)
CA (1) CA2180730C (de)
DE (1) DE69513383T2 (de)
DK (1) DK0741726T3 (de)
ES (1) ES2140717T3 (de)
FI (1) FI962954A0 (de)
GB (1) GB9423997D0 (de)
GR (1) GR3032535T3 (de)
HU (1) HUT74875A (de)
IL (1) IL116002A0 (de)
MX (1) MX9602838A (de)
NO (1) NO963066L (de)
NZ (1) NZ295668A (de)
PL (1) PL315689A1 (de)
PT (1) PT741726E (de)
WO (1) WO1996016964A1 (de)
ZA (1) ZA959927B (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316635B1 (en) 1995-06-07 2001-11-13 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
US5880141A (en) 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
US6906093B2 (en) 1995-06-07 2005-06-14 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
US6147106A (en) 1997-08-20 2000-11-14 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
GB9610964D0 (en) * 1996-05-24 1996-07-31 Pharmacia & Upjohn Spa Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
GB9611797D0 (en) * 1996-06-06 1996-08-07 Pharmacia Spa Substituted quinolylmethylen-oxindole analogues as tyrosine kinase inhibitors
GB9613021D0 (en) * 1996-06-21 1996-08-28 Pharmacia Spa Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
US6316429B1 (en) 1997-05-07 2001-11-13 Sugen, Inc. Bicyclic protein kinase inhibitors
US6486185B1 (en) 1997-05-07 2002-11-26 Sugen, Inc. 3-heteroarylidene-2-indolinone protein kinase inhibitors
US6987113B2 (en) 1997-06-11 2006-01-17 Sugen, Inc. Tyrosine kinase inhibitors
GB9718913D0 (en) 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
GB9721437D0 (en) * 1997-10-10 1997-12-10 Glaxo Group Ltd Heteroaromatic compounds and their use in medicine
US6531502B1 (en) 1998-01-21 2003-03-11 Sugen, Inc. 3-Methylidenyl-2-indolinone modulators of protein kinase
AU3363599A (en) * 1998-03-26 1999-10-18 Max-Planck Institut Fur Biochemie Heterocyclic families of compounds for the modulation of tyrosine protein kinase
US6514981B1 (en) 1998-04-02 2003-02-04 Sugen, Inc. Methods of modulating tyrosine protein kinase function with indolinone compounds
US6569868B2 (en) 1998-04-16 2003-05-27 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
AU759226B2 (en) 1998-05-29 2003-04-10 Sugen, Inc. Pyrrole substituted 2-indolinone protein kinase inhibitors
CN1261098C (zh) 1998-08-28 2006-06-28 西奥斯股份有限公司 p38－α激酶的抑制剂
US6153634A (en) 1998-12-17 2000-11-28 Hoffmann-La Roche Inc. 4,5-azolo-oxindoles
BR9916324A (pt) 1998-12-17 2001-10-02 Hoffmann La Roche 4,5-pirazinoxindóis como inibidores de proteìna quinase
KR20010101266A (ko) 1998-12-17 2001-11-14 프리돌린 클라우스너, 롤란드 비. 보레르 Ｊｎｋ 단백질 키나제의 억제제로서의 4-아릴옥신돌
ES2192877T3 (es) * 1998-12-17 2003-10-16 Hoffmann La Roche 4-alquenil (y alquinil) oxindoles como inhibidores de kinasas ciclina-dependientes, en particular cdk2.
US6624171B1 (en) 1999-03-04 2003-09-23 Smithkline Beecham Corporation Substituted aza-oxindole derivatives
GB9904933D0 (en) 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
US6492398B1 (en) 1999-03-04 2002-12-10 Smithkline Beechman Corporation Thiazoloindolinone compounds
US6689806B1 (en) 1999-03-24 2004-02-10 Sugen, Inc. Indolinone compounds as kinase inhibitors
US6541477B2 (en) 1999-08-27 2003-04-01 Scios, Inc. Inhibitors of p38-a kinase
US6878733B1 (en) 1999-11-24 2005-04-12 Sugen, Inc. Formulations for pharmaceutical agents ionizable as free acids or free bases
US6313310B1 (en) 1999-12-15 2001-11-06 Hoffmann-La Roche Inc. 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles
DE60021423T2 (de) * 1999-12-21 2006-04-13 Sugen, Inc., San Diego 4-substituierte 7-aza-indolin-2-one und ihre verwendung als proteinkinaseinhibitoren
US6620818B1 (en) 2000-03-01 2003-09-16 Smithkline Beecham Corporation Method for reducing the severity of side effects of chemotherapy and/or radiation therapy
MY128450A (en) 2000-05-24 2007-02-28 Upjohn Co 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
CA2410509A1 (en) 2000-06-02 2001-12-13 Sugen, Inc. Indolinone derivatives as protein kinase/phosphatase inhibitors
US6335342B1 (en) 2000-06-19 2002-01-01 Pharmacia & Upjohn S.P.A. Azaindole derivatives, process for their preparation, and their use as antitumor agents
WO2002056912A2 (en) 2001-01-16 2002-07-25 Glaxo Group Limited Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
US6504034B2 (en) 2001-01-23 2003-01-07 Hoffmann-La Roche Inc. Naphthostyrils
US7015231B2 (en) * 2001-09-27 2006-03-21 Smithkline Beecham Corporation Chemical compounds
WO2007085188A1 (en) * 2006-01-27 2007-08-02 Shanghai Hengrui Pharmaceutical Co. Ltd. Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
CN101367801B (zh) * 2007-08-15 2011-01-12 上海恒瑞医药有限公司 吡咯并六元n杂环羟基吗啡啉类衍生物的制备方法及其在医药上的应用
US8669363B2 (en) 2011-03-24 2014-03-11 Southern Methodist University Quinoxaline compounds and derivatives
US9493452B2 (en) * 2011-03-24 2016-11-15 Southern Methodist University Compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as raf kinase and LRRK2 inhibitors
US9309208B2 (en) 2012-03-23 2016-04-12 Southern Methodist University Methods of making and using thioxothiazolidine and rhodanine derivatives as HIV-1 and JSP-1 inhibitors
CN103864784B (zh) * 2014-02-28 2017-05-03 温州医科大学 一种新型氮杂吲哚‑2‑酮类fgfr1抑制剂及其抗肿瘤活性
US20230312561A1 (en) * 2020-07-01 2023-10-05 Angion Biomedica Corp. Solid forms of (z)-methyl 3-(((4-(n-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxo-2,3-dihydro-1h-pyrrolo[2,3-b]pyridine-6-carboxylate and salts thereof
EP4255422A1 (de) 2020-12-03 2023-10-11 Mydecine Innovations Group Inc. Neue psilocinanalogazusammensetzungen und verfahren zur synthese davon
WO2024071415A1 (ja) * 2022-09-30 2024-04-04 日本ポリケム株式会社 化合物、金属錯体、オレフィン重合用触媒組成物、オレフィン重合用触媒、及び、オレフィン系重合体の製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9226855D0 (en) * 1992-12-23 1993-02-17 Erba Carlo Spa Vinylene-azaindole derivatives and process for their preparation

Also Published As

Publication number Publication date
IL116002A0 (en) 1996-01-31
CN1139929A (zh) 1997-01-08
CA2180730C (en) 2006-09-12
DK0741726T3 (da) 2000-04-17
NO963066D0 (no) 1996-07-23
ATE186727T1 (de) 1999-12-15
GR3032535T3 (en) 2000-05-31
DE69513383D1 (de) 1999-12-23
EP0741726A1 (de) 1996-11-13
WO1996016964A1 (en) 1996-06-06
JPH09508924A (ja) 1997-09-09
GB9423997D0 (en) 1995-01-11
HUT74875A (en) 1997-02-28
NZ295668A (en) 1997-11-24
CA2180730A1 (en) 1996-06-06
US5719135A (en) 1998-02-17
PT741726E (pt) 2000-04-28
PL315689A1 (en) 1996-11-25
FI962954A (fi) 1996-07-24
DE69513383T2 (de) 2000-05-18
EP0741726B1 (de) 1999-11-17
ZA959927B (en) 1996-06-10
HU9602357D0 (en) 1996-11-28
FI962954A0 (fi) 1996-07-24
AU3926295A (en) 1996-06-19
ES2140717T3 (es) 2000-03-01
MX9602838A (es) 1997-06-28

Similar Documents

Publication Publication Date Title
NO963066D0 (no) Substituerte 3-aryliden-7-azaoksindolforbindelser og fremgangsmåte for deres fremstilling
DK0715628T3 (da) Substituerede azaindolyliden-forbindelser og fremgangsmåde til fremstilling deraf
DE69512797D1 (en) Prostaglandin-synthase hemmer
NZ511739A (en) New esters derived from substituted phenyl-cyclohexyl compounds
ES8308543A1 (es) "procedimiento para la preparacion de nuevas 2-fenil-2-(piridiloxi)-etilaminas sustituidas".
ES535411A0 (es) Procedimiento para preparar nuevos derivados del acido 4-fenil-4-oxo-buten-2-oico
EA200101109A1 (ru) Производные 1-трифторметил-4-гидрокси-7-пиперидинил-аминометилхромана
NO166321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinforbindelser.
HUP0003856A2 (hu) 6-Pirrolidin-2-ilpirindin-származékok, eljárás előállításukra és gyógyászati alkalmazásuk
HU894471D0 (en) Process for the preparation of 15-amino-20,21-dinor-eburnamenine derivatives and pharmaceutical compositions containing them
PT77728A (en) Process for preparing acridanone derivatives and of pharmaceutical compositions containing the same